| As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO | Ben Fidler | 11/14/14 | San Francisco |
| West Coast Biotech Roundup: Affymax, K2, Roche/Stratos, & More | Alex Lash | 06/26/14 | San Francisco |
| Affymax Cuts 230 Jobs, Mulls Bankruptcy, After Drug Withdrawal | Luke Timmerman | 03/18/13 | San Francisco |
| Has The Pendulum Swung Too Far in Favor of Rare Diseases? | Stewart Lyman | 03/14/13 | Seattle |
| Some Bold Baseball and Biotech Picks for the 2013 Season | Luke Timmerman | 03/11/13 | National |
| Affymax, Takeda Win Approval of Anemia Drug to Challenge Amgen | Luke Timmerman | 03/27/12 | San Francisco |
